Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Clinical Trial Lab Research
New Trial Data Shows ALTUVIIIO™ Prophylaxis Effective in Children
Jul 3, 2023
Industry
FDA Approval
Hemophilia A Gene Therapy Product Receives U.S. FDA Approval
Jun 30, 2023
Industry
First Hemophilia B Patient Dosed with Gene Therapy Product
Jun 20, 2023
Industry
Research Blood Disorder Vial
Pfizer Highlights Phase 3 Trial Results of Marstacimab
May 31, 2023
Industry
Research Blood Disorder Vial
FDA Requests Additional Information on Concizumab from Novo Nordisk
May 5, 2023
Industry
Two Doctors/Researchers discussing data
Sanofi Announces Publication of Two Phase 3 Fitusiran Trials
Apr 6, 2023
Industry
Clinical Trial Gene Double Helix
BioMarin Announces FDA’s Extended Review of Investigational…
Mar 10, 2023
Industry
FDA Approval
uniQure Announces Published Trial Results for Approved Gene Therapy
Feb 27, 2023
Industry
FDA Approval
FDA Approves ALTUVIIIO™ for Hemophilia A Patients
Feb 24, 2023
Industry
Female Scientist Conducting Research in Lab Analyzing Data
Sanofi Announces New Efanesoctocog alfa Data Published in the NEJM
Jan 30, 2023
Industry
Scientist Pipetting Liquids for Research
New FIX Chromogenic Assay Launched by Precision BioLogic
Jan 18, 2023
Industry
Biomarin Provides Hemophilia A Clinical Development Program Updates
Biomarin Provides Hemophilia A Clinical Development Program Updates
Jan 10, 2023
Industry
Takeda Announces Trial Results on Investigational Therapy for Ultra Rare Blood Disorder
Takeda Announces Trial Results on Investigational Therapy for…
Jan 10, 2023
Industry
Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy
Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy…
Jan 4, 2023
Industry
Clinical Trial Lab Research
Spark Announces SPK-8011 Updates at ASH
Dec 15, 2022